Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 272Lymphoma, Large B-Cell, Diffuse 259Leukemia, Lymphocytic, Chronic, B-Cell 189Lymphoma, Non-Hodgkin 187Lymphoma, Mantle-Cell 165Lymphoma, Follicular 164Lymphoma, B-Cell, Marginal Zone 115Leukemia 94Burkitt Lymphoma 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Waldenstrom Macroglobulinemia 77Lymphoma, B-Cell 62Recurrence 51Hodgkin Disease 50Lymphoma, Large-Cell, Immunoblastic 44Lymphoma, Large-Cell, Anaplastic 20Leukemia, Myeloid, Acute 20Myelodysplastic Syndromes 18Intraocular Lymphoma 15Hematologic Neoplasms 15Neoplasms 14Dendritic Cell Sarcoma, Interdigitating 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Multiple Myeloma 13Leukemia, Hairy Cell 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Neoplasms, Plasma Cell 10Leukemia, Prolymphocytic 10Lymphoma, T-Cell 9Leukemia, Myelomonocytic, Chronic 9

Interventions

Dexamethasone 8Bortezomib 7Cyclophosphamide 6Lenalidomide 4isatuximab 3glucarpidase 3Calcium Dobesilate 3Thalidomide 2Kidney Transplantation 2Blood Specimen Collection 2Bendamustine Hydrochloride 2pomalidomide 1gamma-Glutamyl Hydrolase 1dexamethasone acetate 1dexamethasone 21-phosphate 1daratumumab 1auricularum 1Whole-Body Irradiation 1Urination 1Urinalysis 1Stents 1Standard of Care 1Rituximab 1Ranitidine 1Nephrotomy 1Nephrostomy, Percutaneous 1Methotrexate 1Leucovorin 1Ice 1Hematologic Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Renal Insufficiency × Rituximab × Clear all
NCT01832922 2018-03-30

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
8 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡